{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T10:35:11Z","timestamp":1786617311973,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd012905","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000}}],"reference-count":90,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012905.pub2","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T06:55:33Z","timestamp":1732776933000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Fenoldopam for preventing and treating acute kidney injury"],"prefix":"10.1002","volume":"2024","author":[{"given":"Christopher I","family":"Esezobor","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; College of Medicine, University of Lagos; Lagos Nigeria"},{"name":"Department of Pediatrics; Eastern Virginia Medical School at Old Dominion University; Norfolk Virginia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish C","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Department of Pediatrics; All India Institute of Medical Sciences (AIIMS); Bhopal India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel E","family":"Effa","sequence":"additional","affiliation":[{"name":"Internal Medicine; College of Medical Sciences, University of Calabar; Calabar Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth M","family":"Hodson","sequence":"additional","affiliation":[{"name":"Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD012905.pub2-BIB0001|cit1","first-page":"279","article-title":"Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy","volume":"57","author":"Allaqaband","year":"2002","journal-title":"Catheterization & Cardiovascular Interventions"},{"issue":"5","key":"10.1002\/14651858.CD012905.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/CCM.0b013e31816f48ba","article-title":"N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery","volume":"36","author":"Barr","year":"2008","journal-title":"Critical Care Medicine"},{"issue":"8","key":"10.1002\/14651858.CD012905.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/lt.20145","article-title":"Use of fenoldopam to control renal dysfunction early after liver transplantation","volume":"10","author":"Biancofiore","year":"2004","journal-title":"Liver Transplantation"},{"issue":"24","key":"10.1002\/14651858.CD012905.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1161\/CIRCULATIONAHA.104.509141","article-title":"Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial","volume":"111","author":"Bove","year":"2005","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD012905.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.CCM.0000201884.08872.A2","article-title":"A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients","volume":"34","author":"Brienza","year":"2006","journal-title":"Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012905.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jacc.2004.04.052","article-title":"N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity","volume":"44","author":"Briguori","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD012905.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijcard.2005.06.038","article-title":"Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN)","volume":"109","author":"Ng","year":"2006","journal-title":"International Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD012905.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1053-0770(03)00155-1","article-title":"Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass","volume":"17","author":"Caimmi","year":"2003","journal-title":"Journal of Cardiothoracic & Vascular Anesthesia"},{"issue":"4","key":"10.1002\/14651858.CD012905.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1755-5922.2010.00217.x","article-title":"Fenoldopam in critically ill patients with early renal dysfunction. A crossover study","volume":"29","author":"Cobas","year":"2011","journal-title":"Cardiovascular Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD012905.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/dat.20538","article-title":"Fenoldopam in critically ill patients with early renal dysfunction: A crossover study","volume":"40","author":"Paparcuri","year":"2011","journal-title":"Dialysis & Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD012905.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1053\/j.jvca.2007.02.022","article-title":"Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study","volume":"21","author":"Cogliati","year":"2007","journal-title":"Journal of Cardiothoracic & Vascular Anesthesia"},{"issue":"17","key":"10.1002\/14651858.CD012905.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1001\/jama.290.17.2284","article-title":"Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial","volume":"290","author":"Stone","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD012905.pub2-BIB0013|cit13","first-page":"S31","article-title":"Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy","volume":"2 Suppl 1","author":"Stone","year":"2001","journal-title":"Reviews in Cardiovascular Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012905.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1213\/01.ANE.0000136420.01393.81","article-title":"Fenoldopam mesylate and renal function in patients undergoing liver transplantation: a randomized, controlled pilot trial","volume":"99","author":"Della Rocca","year":"2004","journal-title":"Anesthesia & Analgesia"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012905.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijcme.2015.05.021","article-title":"Fenoldopam for prevention of Acute kidNey injury in patients with aCute coronarY syndrome undergoing coronary angiography and\/or percutaneous coronary Intervention \u2014 The FANCY trial [abstract]","volume":"7","author":"Pristipino","year":"2015","journal-title":"IJC Metabolic & Endocrine"},{"issue":"21","key":"10.1002\/14651858.CD012905.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1001\/jama.2014.13573","article-title":"Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial","volume":"312","author":"Bove","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD012905.pub2-BIB0017|cit17","first-page":"111","article-title":"Fenoldopam to prevent renal replacement therapy after cardiac surgery. Design of the FENO-HSR study","volume":"2","author":"Landoni","year":"2010","journal-title":"HSR Proceedings in Intensive Care & Cardiovascular Anesthesia"},{"issue":"10","key":"10.1002\/14651858.CD012905.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-2044.2001.02220.x","article-title":"Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting","volume":"56","author":"Halpenny","year":"2001","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1002\/14651858.CD012905.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00003643-200201000-00005","article-title":"The effects of fenoldopam on renal function in patients undergoing elective aortic surgery","volume":"19","author":"Halpenny","year":"2002","journal-title":"European Journal of Anaesthesiology"},{"issue":"1","key":"10.1002\/14651858.CD012905.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.22514\/SV61.052011.2","article-title":"Perioperative fenoldopam for the prevention of acute renal failure in non-cardiac surgery, randomized clinical trial","volume":"6","author":"Memmo","year":"2011","journal-title":"Signa Vitae"},{"issue":"11","key":"10.1002\/14651858.CD012905.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1097\/01.CCM.0000186413.04875.EF","article-title":"Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial","volume":"33","author":"Morelli","year":"2005","journal-title":"Critical Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012905.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1569-9056(11)60600-3","article-title":"The effect of fenoldopam on renal function in solitary partial nephrectomy surgery [abstract no: 610]","volume":"10","author":"Fergany","year":"2011","journal-title":"European Urology Supplements"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD012905.pub2-BIB0023|cit23","first-page":"e280","article-title":"The effect of fenoldopam on renal function in solitary kidney partial nephrectomy [abstract no: 696]","volume":"185","author":"Fergany","year":"2011","journal-title":"Journal of Urology"},{"issue":"2","key":"10.1002\/14651858.CD012905.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.urology.2012.09.041","article-title":"Fenoldopam and renal function after partial nephrectomy in a solitary kidney: a randomized, blinded trial","volume":"81","author":"Mahboobi","year":"2013","journal-title":"Urology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012905.pub2-BIB0025|cit25","first-page":"S16","article-title":"Fenoldopam renal effects in solitary partial nephrectomy [abstract no: 1066503]","volume":"58","author":"O'Hara","year":"2011","journal-title":"Canadian Journal of Anesthesia"},{"issue":"Oct","key":"10.1002\/14651858.CD012905.pub2-BIB0026|cit26","first-page":"39A","article-title":"A prospective randomized control trial: an evaluation of the use of Fenoldopam (FEN) and N-Acetylcysteine (NAC) with different osmolar contrast agents in the prevention of radiocontrast nephropathy (RCN) (PREVENT STUDY) [abstract no: SA-FC084]","volume":"15","author":"Devine","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD012905.pub2-BIB0027|cit27","first-page":"249","article-title":"Effects of fenoldopam infusion in complex cardiac surgical operations: A prospective, randomized, double-blind, placebo-controlled study","volume":"76","author":"Ranucci","year":"2010","journal-title":"Minerva Anestesiologica"},{"issue":"3","key":"10.1002\/14651858.CD012905.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"R160","DOI":"10.1186\/cc10295","article-title":"High-dose fenoldopam reduces postoperative neutrophil gelatinase-associated lipocaline and cystatin C levels in pediatric cardiac surgery","volume":"15","author":"Ricci","year":"2011","journal-title":"Critical Care (London, England)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012905.pub2-BIB0029|cit29","first-page":"69","article-title":"Effects of fenoldopam on renal function in critically ill patients undergoing a strictly conservative strategy of fluid management [abstract no: P170]","volume":"22","author":"Tribuzi","year":"2018","journal-title":"Critical Care (London, England)"},{"issue":"Sept","key":"10.1002\/14651858.CD012905.pub2-BIB0030|cit30","first-page":"135A","article-title":"A multicenter, double-blind, placebo-controlled trial of fenoldopam mesylate in the prevention of radiocontrast nephropathy in patients with moderate to severe renal insufficiency [abstract no: A0728]","volume":"11","author":"Tumlin","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD012905.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1067\/mhj.2002.122118","article-title":"Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy","volume":"143","author":"Tumlin","year":"2002","journal-title":"American Heart Journal"},{"issue":"Nov","key":"10.1002\/14651858.CD012905.pub2-BIB0032|cit32","first-page":"774A","article-title":"Dopamine receptor 1 agonists in early acute tubular necrosis: a prospective, randomized, double blind, placebo-controlled trial of fenoldopam mesylate [abstract no: PUB001]","volume":"14","author":"Tumlin","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD012905.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.ajkd.2005.04.002","article-title":"Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial","volume":"46","author":"Tumlin","year":"2005","journal-title":"American Journal of Kidney Diseases"},{"issue":"6","key":"10.1002\/14651858.CD012905.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ejcts.2009.01.024","article-title":"The effect of fenoldopam and dopexamine on hepatic blood flow and hepatic function following coronary artery bypass grafting with hypothermic cardiopulmonary bypass","volume":"35","author":"Adluri","year":"2009","journal-title":"European Journal of Cardio-Thoracic Surgery"},{"issue":"6","key":"10.1002\/14651858.CD012905.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"E353","DOI":"10.1532\/HSF98.20101073","article-title":"The effect of fenoldopam and dopexamine on cytokine and endotoxin release following on-pump coronary artery bypass grafting: a prospective randomized double-blind trial","volume":"13","author":"Adluri","year":"2010","journal-title":"Heart Surgery Forum"},{"issue":"3","key":"10.1002\/14651858.CD012905.pub2-BIB0036|cit36","first-page":"855","article-title":"DA1 receptor agonist lowers renal vascular resistance in kidney transplant patients on cyclosporine [abstract no: 106P]","volume":"3","author":"Curtis","year":"1992","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD012905.pub2-BIB0037|cit37","unstructured":"Hochstetler M Fallon W A pilot study to investigate fenoldopam usage in the prevention of postoperative renal dysfunction in patients at a high risk for renal impairment during cariopulmonary bypass for cardiac surgery www.clinicaltrials.gov\/ct2\/show\/NCT00467181"},{"key":"10.1002\/14651858.CD012905.pub2-BIB0038|cit38","unstructured":"Klajbor K Lango R Fenoldopam and ketanserin for acute kidney failure prevention after cardiac surgery www.clinicaltrials.gov\/ct2\/show\/NCT00557219"},{"key":"10.1002\/14651858.CD012905.pub2-BIB0039|cit39","unstructured":"Tumlin J Intra-renal therapy of diuretic unresponsive acute kidney injury www.clinicaltrials.gov\/ct2\/show\/NCT01073189"},{"key":"10.1002\/14651858.CD012905.pub2-BIB0040|cit40","unstructured":"Segar J Fenoldopam to prevent renal dysfunction in indomethacin treated preterm infants www.clinicaltrials.gov\/ct2\/show\/NCT02620761"},{"issue":"6","key":"10.1002\/14651858.CD012905.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.transproceed.2007.05.065","article-title":"Fenoldopam vs dopamine as a nephroprotective strategy during living donor kidney transplantation: preliminary data","volume":"39","author":"Sorbello","year":"2007","journal-title":"Transplantation Proceedings"},{"issue":"Oct","key":"10.1002\/14651858.CD012905.pub2-BIB0042|cit42","first-page":"346A","article-title":"Targeted renal drug delivery with fenoldopam: a multicenter, randomized, controlled trial [abstract no: SA-PO211]","volume":"15","author":"Mathur","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD012905.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.amjcard.2005.10.053","article-title":"Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization","volume":"97","author":"Teirstein","year":"2006","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD012905.pub2-BIB0044|cit44","first-page":"914A","article-title":"Design and rationale for the Targeted Intra-renal Fenoldopam For Avoidance of NephropathY (TIFFANY) trial [abstract no: PUB607]","volume":"16","author":"Teirstein","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstracts Issue","key":"10.1002\/14651858.CD012905.pub2-BIB0045|cit45","first-page":"787A","article-title":"Efficacy of combination intrarenal fenoldopam and mesna therapy in contrast nephropathy: a randomized placebo controlled trial [abstract no: SA-PO2981]","volume":"19","author":"Tumlin","year":"2008","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD012905.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000095350","article-title":"Fenoldopam improves corticomedullary oxygen delivery and attenuates angiogenesis gene expression in acute ischemic renal injury","volume":"29","author":"Aravindan","year":"2006","journal-title":"Kidney & Blood Pressure Research"},{"issue":"1","key":"10.1002\/14651858.CD012905.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1441-2772(23)02007-0","article-title":"Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis","volume":"9","author":"Bagshaw","year":"2007","journal-title":"Critical Care & Resuscitation"},{"issue":"4","key":"10.1002\/14651858.CD012905.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure \u2013 definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Critical Care (London, England)"},{"issue":"9843","key":"10.1002\/14651858.CD012905.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","article-title":"Acute kidney injury","volume":"380","author":"Bellomo","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD012905.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jpeds.2006.03.053","article-title":"Theophylline for renal function in term neonates with perinatal asphyxia: a randomized, placebo-controlled trial","volume":"149","author":"Bhat","year":"2006","journal-title":"Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD012905.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2165\/00003495-199754040-00008","article-title":"Fenoldopam: a review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies","volume":"54","author":"Brogden","year":"1997","journal-title":"Drugs"},{"issue":"5","key":"10.1002\/14651858.CD012905.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD012905.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1164\/rccm.200109-016OC","article-title":"Microvascular blood flow is altered in patients with sepsis","volume":"166","author":"De Backer","year":"2002","journal-title":"American Journal Respiratory & Critical Care Medicine"},{"key":"10.1002\/14651858.CD012905.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s13054-015-1166-4","article-title":"Fenoldopam to prevent acute kidney injury after major surgery- a systematic review and meta-analysis","volume":"19","author":"Gillies","year":"2015","journal-title":"Critical Care (London, England)"},{"issue":"2","key":"10.1002\/14651858.CD012905.pub2-BIB0055|cit55","first-page":"179","article-title":"Renal and endocrine effects of fenoldopam and metoclopramide in normal man","volume":"56","author":"Girbes","year":"1990","journal-title":"Nephron"},{"issue":"4A","key":"10.1002\/14651858.CD012905.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-9343(84)80036-4","article-title":"Dopamine receptors and hypertension. Physiologic and pharmacologic implications","volume":"77","author":"Goldberg","year":"1984","journal-title":"American Journal of Medicine"},{"issue":"7650","key":"10.1002\/14651858.CD012905.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD012905.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012905.pub2-BIB0059|cit59","volume-title":"Primer on Kidney Diseases","author":"Greenberg","year":"2009"},{"issue":"2","key":"10.1002\/14651858.CD012905.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0022-3565(25)33333-1","article-title":"Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist","volume":"223","author":"Hahn","year":"1982","journal-title":"Journal of Pharmacology & Experimental Therapeutics"},{"issue":"7414","key":"10.1002\/14651858.CD012905.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012905.pub2-BIB0062|cit62","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD012905.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","journal-title":"Kidney International - Supplement"},{"issue":"7","key":"10.1002\/14651858.CD012905.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/ndt\/gfu016","article-title":"The economic impact of acute kidney injury in England","volume":"29","author":"Kerr","year":"2014","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD012905.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"e34584","DOI":"10.7759\/cureus.34584","article-title":"Beneficial impacts of fenoldopam on patients with or at risk for acute renal failure and undergoing surgery: a meta-analysis of randomized clinical trials","volume":"15","author":"Kondabolu","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1002\/14651858.CD012905.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.ajkd.2006.10.013","article-title":"Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials","volume":"49","author":"Landoni","year":"2007","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"10.1002\/14651858.CD012905.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/j.jvca.2007.07.015","article-title":"Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis","volume":"22","author":"Landoni","year":"2008","journal-title":"Journal of Cardiothoracic & Vascular Anesthesia"},{"issue":"6","key":"10.1002\/14651858.CD012905.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1097\/01.ASN.0000130340.93930.DD","article-title":"Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study","volume":"15","author":"Lassnigg","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD012905.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1097\/01.CCM.0000182798.39709.84","article-title":"Early changes in organ function predict eventual survival in severe sepsis","volume":"33","author":"Levy","year":"2005","journal-title":"Critical Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012905.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Critical Care (London, England)"},{"issue":"10032","key":"10.1002\/14651858.CD012905.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/S0140-6736(16)30240-9","article-title":"Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study [Erratum in: Lancet. 2016 May 14;387(10032):1998]","volume":"387","author":"Mehta","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD012905.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1681\/ASN.2010050442","article-title":"Statin use associates with a lower incidence of acute kidney injury after major elective surgery","volume":"22","author":"Molnar","year":"2011","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD012905.pub2-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006028.pub2","article-title":"Atrial natriuretic peptide for preventing and treating acute kidney injury","author":"Nigwekar","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012905.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1016\/S2214-109X(15)00322-8","article-title":"Outcomes of acute kidney injury in children and adults in sub-Saharan Africa: a systematic review","volume":"4","author":"Olowu","year":"2016","journal-title":"The Lancet Global Health"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD012905.pub2-BIB0075|cit75","first-page":"F627","article-title":"Tubuloglomerular feedback and blood flow autoregulation during DA1-induced renal vasodilation","volume":"258","author":"Pollock","year":"1990","journal-title":"American Journal of Physiology"},{"key":"10.1002\/14651858.CD012905.pub2-BIB0076|cit76","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD012905.pub2-BIB0077|cit77","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"5","key":"10.1002\/14651858.CD012905.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0272-6386(98)70043-5","article-title":"Potential of dopamine A-1 agonists in the management of acute renal failure","volume":"31","author":"Singer","year":"1998","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"10.1002\/14651858.CD012905.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2016.07.033","article-title":"Comparative effectiveness of 12 treatment strategies for preventing contrast-induced acute kidney injury: a systematic review and bayesian network meta-analysis","volume":"69","author":"Su","year":"2017","journal-title":"American Journal of Kidney Diseases"},{"issue":"3","key":"10.1002\/14651858.CD012905.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/SHK.0000000000001313","article-title":"Does fenoldopam protect kidney in cardiac surgery? A systemic review and meta-analysis with trial sequential analysis","volume":"52","author":"Sun","year":"2019","journal-title":"Shock"},{"issue":"9","key":"10.1002\/14651858.CD012905.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.2215\/CJN.00710113","article-title":"World incidence of AKI: a meta-analysis.[Erratum appears in Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1148]","volume":"8","author":"Susantitaphong","year":"2013","journal-title":"Clinical Journal of the American Society of Nephrology: CJASN"},{"issue":"6","key":"10.1002\/14651858.CD012905.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"F1324","DOI":"10.1152\/ajprenal.00124.2005","article-title":"Disruption of renal peritubular blood flow in lipopolysaccharide-induced renal failure: role of nitric oxide and caspases","volume":"289","author":"Tiwari","year":"2005","journal-title":"American Journal of Physiology - Renal Physiology"},{"issue":"7","key":"10.1002\/14651858.CD012905.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.294.7.813","article-title":"Acute renal failure in critically ill patients: a multinational, multicenter study","volume":"294","author":"Uchino","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD012905.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ajpath.2011.10.011","article-title":"Development of oxidative stress in the peritubular capillary microenvironment mediates sepsis-induced renal microcirculatory failure and acute kidney injury","volume":"180","author":"Wang","year":"2012","journal-title":"American Journal of Pathology"},{"issue":"1","key":"10.1002\/14651858.CD012905.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2125.1988.tb03276.x","article-title":"Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients","volume":"25","author":"Weber","year":"1988","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012905.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"e85029","DOI":"10.1371\/journal.pone.0085029","article-title":"Intravascular administration of mannitol for acute kidney injury prevention: a systematic review and meta-analysis","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS ONE (Electronic Resource]"},{"issue":"9","key":"10.1002\/14651858.CD012905.pub2-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003590.pub4","article-title":"Interventions for protecting renal function in the perioperative period","author":"Zacharias","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012905.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1053\/j.jvca.2012.01.038","article-title":"Fenoldopam and acute renal failure in cardiac surgery: a meta-analysis of randomized placebo-controlled trials","volume":"26","author":"Zangrillo","year":"2012","journal-title":"Journal of Cardiothoracic & Vascular Anesthesia"},{"issue":"3","key":"10.1002\/14651858.CD012905.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/clpt.1987.28","article-title":"The effect of acetaminophen on the disposition of fenoldopam: competition for sulfation","volume":"41","author":"Ziemniak","year":"1987","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"12","key":"10.1002\/14651858.CD012905.pub2-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012905","article-title":"Fenoldopam for preventing and treating acute kidney injury","author":"Esezobor","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T10:05:48Z","timestamp":1786615548000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012905.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":90,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012905.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]}}}